Lupin receives FDA Approval for Generic version of Zyvox Tablets

LupinPharma Major Lupin Limited announced today that its US subsidiary, Gavis Pharmaceuticals has received final approval for its Linezolid Tablets from the United States Food and Drug Administration (FDA).

The drug is a generic equivalent of Pharmacia & Upjohn Company’s Zyvox Tablets, 600 mg.

Zyvox Tablets had US sales of USD 273.6 million the company further added.

Last week Lupin had received approval to launch Acotiamide 100 mg indigestion tablets in India from the Central Drugs Standard Control Organization.